A messenger at the door: cytomegalovirus retinitis in myeloma patients with progressive disease
- 23 June 2013
- journal article
- case report
- Published by Wiley in Transplant Infectious Disease
- Vol. 15 (4) , E134-E138
Abstract
Cytomegalovirus (CMV) retinitis is an uncommon manifestation of CMV disease and is a marker of severe and profound immunosuppression in human immunodeficiency virus‐positive patients. Here, we describe 2 cases of CMV retinitis in myeloma patients with progressive disease, following autologous stem cell transplantation and immunomodulatory therapy for myeloma. To our knowledge, this is the first report of CMV retinitis in this patient population. This report illustrates the need for close monitoring of relapsed and refractory myeloma patients for new presentations of opportunistic infections secondary to severe immunosuppression.Keywords
This publication has 19 references indexed in Scilit:
- Cytomegalovirus Reactivation Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma in the Era of Novel Chemotherapeutics and Tandem TransplantationTransplantation and Cellular Therapy, 2012
- CMV Retinopathy in the Antiretroviral Therapy Era: Prevention, Diagnosis, and ManagementCurrent Infectious Disease Reports, 2012
- Complications, Diagnosis, Management, and Prevention of CMV Infections: Current and FutureHematology-American Society Hematology Education Program, 2011
- Clinical features and outcomes of cytomegalovirus retinitis after transplantationTransplant Infectious Disease, 2007
- Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance programTransplant Infectious Disease, 2005
- Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infectionAmerican Journal of Ophthalmology, 2004
- Definitions of Cytomegalovirus Infection and Disease in Transplant RecipientsClinical Infectious Diseases, 2002
- Virological, Clinical, and Ophthalmologic Features of Cytomegalovirus Retinitis after Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2001
- Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoringBlood, 2000
- Increased Incidence of Cytomegalovirus Disease After Autologous CD34-Selected Peripheral Blood Stem Cell TransplantationBlood, 1999